Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=48964#.VJjkCcCAM4
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=48964#.VJjkCcCAM4
Author(s)
Research Center for Drug Discovery Technology, Korea Research Institute of Chemical Technology, Daejeon, South Korea
Department of Medicinal and Pharmaceutical Chemistry, University of Science and Technology, Daejeon,
South Korea.
Research Center for Drug Discovery Technology, Korea Research Institute of Chemical Technology, Daejeon, South Korea.
Research Center for Drug Discovery Technology, Korea Research Institute of Chemical Technology, Daejeon, South Korea.
Research Center for Drug Discovery Technology, Korea Research Institute of Chemical Technology, Daejeon, South Korea.
Research Center for Drug Discovery Technology, Korea Research Institute of Chemical Technology, Daejeon, South Korea Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon, South Korea.
Research Center for Drug Discovery Technology, Korea Research Institute of Chemical Technology, Daejeon, South Korea Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon, South Korea.
Research Center for Drug Discovery Technology, Korea Research Institute of Chemical Technology, Daejeon, South Korea.
Research Center for Drug Discovery Technology, Korea Research Institute of Chemical Technology, Daejeon, South Korea.
Research Center for Drug Discovery Technology, Korea Research Institute of Chemical Technology, Daejeon, South Korea.
Research Center for Drug Discovery Technology, Korea Research Institute of Chemical Technology, Daejeon, South Korea Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon, South Korea.
Research Center for Drug Discovery Technology, Korea Research Institute of Chemical Technology, Daejeon, South Korea Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon, South Korea.
Polymyxin B is
widely used antibiotic in the clinic for resistant Gram-negative infections. In
addition, polymyxin B-immobilized hemoperfusion cartridge has been used for
endotoxin removal therapy in patients with septic shock. The aim of this study
was to investigate the anti-fibrotic and anti-cellular hypertrophic effects of
polymyxin B, and further to explore its possible mechanism. Polymyxin B (3, 10
μM) significantly inhibited stress fiber formation induced by angiotensin II
(Ang II) in rat heart-derived H9c2 cells. Furthermore, polymyxin B (1 - 10 μM)
showed a potent inhibitory effect on Ang II-induced cellular hypertrophy in
H9c2 cells. Under the mechanism study, the inhibitory activities of polymyxin B
against kinases involved in cellular hypertrophy such as AKT1, CAMK, GRK5, GSK3β, MLCK, PKC, PKD2, AMPK, ROCK2, p70S6K,
SGK1were evaluated. Polymyxin B possesses a potent G protein related kinase 5
(GKR5) inhibitory activity with IC50 value of 1.1 μM, and has an ATP
non-competitive inhibitory mode. Taken together, these results indicate that
polymyxin B alleviates Ang II-induced stress fiber formation and cellular
hypertrophy, and propose that one mechanism underlying these effects involves
inhibition of the GRK5 pathway.
KEYWORDS
Cite this paper
Oh, K. , Lee, J. , Oh, B. , Mun, J. , Park, B. and
Lee, B. (2014) Polymyxin B Alleviates Angiotensin II-Induced Stress
Fiber Formation and Cellular Hypertrophy. Pharmacology & Pharmacy, 5, 903-910. doi: 10.4236/pp.2014.59101.
| [1] |
Chaponnier, C. and Gabbiani, G.
(2004) Pathological Situations Characterized by Altered Actin Isoform
Expression. Journal of Pathology, 204, 386-395. http://dx.doi.org/10.1002/path.1635 |
| [2] |
Olivetti, G., Melissari, M.,
Capasso, J.M. and Anversa, P. (1991) Cardiomyopathy of the Aging Human
Heart. Myocyte Loss and Reactive Cellular Hypertrophy. Circulation
Research, 68, 1560-1568. http://dx.doi.org/10.1161/01.RES.68.6.1560 |
| [3] |
Zeidan, A., Javadov, S. and
Karmazyn, M. (2006) Essential Role of Rho/ROCK-Dependent Processes and
Actin Dynamics in Mediating Leptin-Induced Hypertrophy in Rat Neonatal
Ventricular Myocytes. Cardiovascular Research, 72, 101-111. http://dx.doi.org/10.1016/j.cardiores.2006.06.024 |
| [4] |
Balasubramanian, S., Mani, S.K.,
Kasiganesan, H., Baicu, C.C. and Kuppuswamy, D. (2010) Hypertrophic
Stimulation Increases Beta-Actin Dynamics in Adult Feline
Cardiomyocytes. PLoS ONE, 5, e11470. http://dx.doi.org/10.1371/journal.pone.0011470 |
| [5] |
Oh, K.S., Oh, B.K., Park, C.H.,
Seo, H.W., Kang, N.S., Lee, J.H., Lee, J.S. and Lee, B.H. (2013)
Cardiovascular Effects of a Novel Selective Rho Kinase Inhibitor,
2-(1H-Indazole-5-yl)Amino-4-Methoxy-6-Piperazino Triazine (DW1865).
European Journal of Pharmacology, 702, 218-226. http://dx.doi.org/10.1016/j.ejphar.2013.01.027 |
| [6] |
Moey, M., Rajapurohitam, V.,
Zeidan, A. and Karmazyn, M. (2011) Ginseng (Panax quinquefolius)
Attenuates Leptin-Induced Cardiac Hypertrophy through Inhibition of
p115Rho Guanine Nucleotide Exchange Factor-RhoA/Rho-Associated,
Coiled-Coil Containing Protein Kinase-Dependent Mitogen-Activated
Protein Kinase Pathway Activation. Journal of Pharmacology and
Experimental Therapeutics, 339, 746-756. http://dx.doi.org/10.1124/jpet.111.182600 |
| [7] |
Evans, M.E., Feola, D.J. and
Rapp, R.P. (1999) Polymyxin B Sulfate and Colistin: Old Antibiotics for
Emerging Multiresistant Gram-Negative Bacteria. Annals of
Pharmacotherapy, 33, 960-967. http://dx.doi.org/10.1345/aph.18426 |
| [8] |
Zavascki, A.P., Goldani, L.Z.,
Li, J. and Nation, R.L. (2007) Polymyxin B for the Treatment of
Multidrug-Resistant Pathogens: A Critical Review. Journal of
Antimicrobial Chemotherapy, 60, 1206-1215. http://dx.doi.org/10.1093/jac/dkm357 |
| [9] |
Murakami, M., Miyauchi, Y.,
Nishida, M., Okada, H. and Hamano, K. (2009) Direct Hemoperfusion Using
Polymyxin-B Immobilized Fiber for Septic Shock after Cardiac Surgery.
Circulation Journal, 73, 658-661. http://dx.doi.org/10.1253/circj.CJ-08-0503 |
| [10] |
Sato, K., Maekawa, H., Sakurada,
M., Orita, H. and Komatsu, Y. (2011) Direct Hemoperfusion with
Polymyxin B Immobilized Fiber for Abdominal Sepsis in Europe. Surgery
Today, 41, 754-760. http://dx.doi.org/10.1007/s00595-010-4504-9 |
| [11] |
Azad, M.A., Finnin, B.A.,
Poudyal, A., Davis, K., Li, J., Hill, P.A., Nation, R.L., Velkov, T. and
Li, J. (2013) Polymyxin B Induces Apoptosis in Kidney Proximal Tubular
Cells. Antimicrobial Agents and Chemotherapy, 57, 4329-4335. http://dx.doi.org/10.1128/AAC.02587-12 |
| [12] |
Harding, E.A., Jaggar, J.H.,
Squires, P.E. and Dunne, M.J. (1994) Polymyxin B Has Multiple Blocking
Actions on the ATP-Sensitive Potassium Channel in Insulin-Secreting
Cells. Pflugers Archiv: European Journal of Physiology, 426, 31-39. http://dx.doi.org/10.1007/BF00374667 |
| [13] |
Ktenas, T.B., Sotiroudis, T.G.
and Evangelopoulos, A.E. (1989) Effects of Polymyxin B on the
Sarcoplasmic Reticulum Membrane. Bioscience Reports, 9, 573-578. http://dx.doi.org/10.1007/BF01119800 |
| [14] | Aida, Y., Pabst, M.J., Rademacher, J.M., Hatakeyama, T. and Aono, M. (1990) Effects of Polymyxin B on Superoxide Anion Release and Priming in Human Polymorphonuclear Leukocytes. Journal of Leukocyte Biology, 47, 283-291. |
| [15] |
Stutchfield, J., Jones, P.M. and
Howell, S.L. (1986) The Effects of Polymyxin B, a Protein Kinase C
Inhibitor, on Insulin Secretion from Intact and Permeabilized Islets of
Langerhans. Biochemical and Biophysical Research Communications, 136,
1001-1006. http://dx.doi.org/10.1016/0006-291X(86)90432-8 |
| [16] |
Xu, F., Dai, C.L., Peng, S.L.,
Zhao, Y., Jia, C.J., Xu, Y.Q. and Zhao, C. (2014) Polymyxin B Protects
against Hepatic Ischemia/Reperfusion Injury in a Rat Model of
Obstructive Jaundice. Inflammation, 37, 1015-1021. http://dx.doi.org/10.1007/s10753-014-9822-4 |
| [17] | Gysembergh, A., Margonari, H., Loufoua, J., Ovize, A., André-Fouët, X., Minaire, Y. and Ovize, M. (1998) Stretch-Induced Protection Shares a Common Mechanism with Ischemic Preconditioning in Rabbit Heart. American Journal of Physiology-Heart and Circulatory Physiology, 274, H955-H964. |
| [18] | Yelich, M.R., Schieber, C.K., Umporowicz, D.M. and Filkins, J.P. (1992) Polymyxin-B Suppresses Endotoxin-Induced Insulin Hypersecretion in Pancreatic Islets. Circulatory Shock, 38, 85-90. |
| [19] |
McKinsey, T.A. and Kass, D.A.
(2007) Small-Molecule Therapies for Cardiac Hypertrophy: Moving beneath
the Cell Surface. Nature Reviews Drug Discovery, 6, 617-635. http://dx.doi.org/10.1038/nrd2193 |
| [20] |
Sin, Y.Y. and Baillie, G.S.
(2012) Protein Kinase D in the Hypertrophy Pathway. Biochemical Society
Transactions, 40, 287-289. http://dx.doi.org/10.1042/BST20110626 |
| [21] |
Belmonte, S.L. and Blaxall, B.C.
(2012) G Protein-Coupled Receptor Kinase 5: Exploring Its Hype in
Cardiac Hypertrophy. Circulation Research, 111, 957-958. http://dx.doi.org/10.1161/CIRCRESAHA.112.278432 |
| [22] |
Ishizaka, N., Alexander, R.W.,
Laursen, J.B., Kai, H., Fukui, T., Oppermann, M., Lefkowitz, R.J.,
Lyons, P.R. and Griendling, K.K. (1997) G Protein-Coupled Receptor
Kinase 5 in Cultured Vascular Smooth Muscle Cells and Rat Aorta.
Regulation by Angiotensin II and Hypertension. Journal of Biological
Chemistry, 272, 32482-32488. http://dx.doi.org/10.1074/jbc.272.51.32482 |
| [23] |
Thiyagarajan, M.M.,
Stracquatanio, R.P., Pronin, A.N., Evanko, D.S., Benovic, J.L. and
Wedegaertner, P.B. (2004) A Predicted Amphipathic Helix Mediates Plasma
Membrane Localization of GRK5. Journal of Biological Chemistry, 279,
17989-17995. http://dx.doi.org/10.1074/jbc.M310738200 |
| [24] |
Martini, J.S., Raake, P., Vinge,
L.E., DeGeorge Jr., B.R., Chuprun, J.K., Harris, D.M., Gao, E.,
Eckhart, A.D., Pitcher, J.A. and Koch, W.J.(2008) Uncovering G
Protein-Coupled Receptor Kinase-5 as a Histone Deacetylase Kinase in the
Nucleus of Cardiomyocytes. Proceedings of the National Academy of
Sciences of the United States of America, 105, 12457-12462. http://dx.doi.org/10.1073/pnas.0803153105 eww141223lx |
评论
发表评论